BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12743595)

  • 1. Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth.
    Kinoshita I; Leaner V; Katabami M; Manzano RG; Dent P; Sabichi A; Birrer MJ
    Oncogene; 2003 May; 22(18):2710-22. PubMed ID: 12743595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells.
    Hommura F; Katabami M; Leaner VD; Donninger H; Sumter TF; Resar LM; Birrer MJ
    Mol Cancer Res; 2004 May; 2(5):305-14. PubMed ID: 15192124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets.
    Leaner VD; Kinoshita I; Birrer MJ
    Oncogene; 2003 Aug; 22(36):5619-29. PubMed ID: 12944910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel SP3 binding site in the promoter of human IGFBP4 gene: role of SP3 and AP-1 in regulating promoter activity in CaCo2 cells.
    Shen Q; Singh P
    Oncogene; 2004 Apr; 23(14):2454-64. PubMed ID: 14767471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
    Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
    FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p202 levels are negatively regulated by serum growth factors.
    Geng Y; D'Souza S; Xin H; Walter S; Choubey D
    Cell Growth Differ; 2000 Sep; 11(9):475-83. PubMed ID: 11007452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.
    Fiala-Beer E; Lee AC; Murray M
    Int J Biochem Cell Biol; 2007; 39(6):1235-47. PubMed ID: 17481938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation.
    Schlingensiepen KH; Schlingensiepen R; Kunst M; Klinger I; Gerdes W; Seifert W; Brysch W
    Dev Genet; 1993; 14(4):305-12. PubMed ID: 8222345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle.
    Iancu C; Mistry SJ; Arkin S; Atweh GF
    Cancer Res; 2000 Jul; 60(13):3537-41. PubMed ID: 10910066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR; Qi L; Higgins PJ
    J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and production of stathmin in growth plate chondrocytes is cell-maturation dependent.
    Hummert TW; Schwartz Z; Sylvia VL; Dean DD; Hardin RR; Boyan BD
    J Cell Biochem; 2000 Jul; 79(1):150-63. PubMed ID: 10906763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers.
    Maeno K; Masuda A; Yanagisawa K; Konishi H; Osada H; Saito T; Ueda R; Takahashi T
    Oncogene; 2006 Jan; 25(2):271-7. PubMed ID: 16158054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene.
    Miyashita H; Kanemura M; Yamazaki T; Abe M; Sato Y
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):878-84. PubMed ID: 15031128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
    Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
    Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells.
    Su F; Kozak KR; Herschman H; Reddy ST; Farias-Eisner R
    J Neurosci Res; 2007 Jul; 85(9):1952-8. PubMed ID: 17455298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of stathmin gene overexpression in osteosarcoma cells].
    Zhang HZ; Gao P; Yan L; Lin F
    Ai Zheng; 2004 May; 23(5):493-6. PubMed ID: 15142441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trait-associated sequence variation in the bovine growth hormone receptor 1A promoter does not affect promoter activity in vitro.
    Zhou Y; Jiang H
    Anim Genet; 2005 Apr; 36(2):156-9. PubMed ID: 15771728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF1 regulatory element functions as a repressor of tissue plasminogen activator expression.
    Pham NL; Franzen A; Levin EG
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):982-7. PubMed ID: 15044208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.